Teclistamab (Tecvayli; Johnson & Johnson) appears poised to move into earlier lines of care as a monotherapy, as bispecific antibodies made big news in the treatment of blood cancers and disorders on ...

After surgery for colon cancer, many patients face the question of whether follow-up chemotherapy is necessary to prevent a ...

Sometimes people are sober and in recovery from alcohol use disorder (AUD) for several years, but relapse. Why? Alcohol use disorder is a chronic, often relapsing medical condition affecting millions ...

Teclistamab improved PFS, OS in patients who had received up to three previous lines of th ...

Paired bone marrow (BM) samples collected at both diagnosis and relapse/progression from 24 patients initially treated in the Intergroupe Francophone du Myélome (IFM) centers either with bortezomib ...

Ecopipam maintains tic improvement, phase III study shows ...

This transcript has been edited for clarity. John Kane, MD: I am Dr John Kane. I am a professor of psychiatry at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, New ...

Stopping cancer from coming back is the goal of new research from MUSC Hollings Cancer Center, where scientists are targeting cells that fuel the return of an aggressive pediatric brain tumor.

A new study by the Garvan Institute of Medical Research has uncovered a hidden mechanism explaining why breast cancer can return many years after successful treatment. Published in Nature ...